AKT1 and ovarian carcinoma: Moreover, silencing of TRIM11 has suppressed the activation of the phosphatidylinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway in hepatocellular and ovarian cancer cells, respectively [8, 9].